Compare Albertsons Companies Inc (ACI) vs Cronos Group Inc (CRON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Albertsons Companies Inc vs Cronos Group Inc — how do they compare? Albertsons Companies Inc trades at $12.35 (market cap $5.95B), while Cronos Group Inc trades at $3.08 (market cap $1.14B). The key difference: Albertsons Companies Inc is far larger — about 5.2× Cronos Group Inc's market cap, and Albertsons Companies Inc pays a 5.55% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.
| ACI | CRON | |
|---|---|---|
Market Cap | $5.95B | $1.14B |
Sector | Consumer Staples | Health |
52-Week High | $19.74 | $3.27 |
52-Week Low | $11.03 | $2.30 |
Enterprise Value | $21.35B | $341.13M |
Dividend Yield | 5.55% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Albertsons Companies Inc
Albertsons is the second-largest traditional grocer in America, operating 2,276 stores under 24 banners in 34 states (as of the end of fiscal 2021). Around 75% of stores have pharmacies, while nearly 20% also sell fuel. Albertsons has a significant private-label operation, accounting for around 20% of sales (excluding fuel). While its own brand assortment is mainly manufactured by third parties, Albertsons operates 20 food production plants (as of the end of fiscal 2021). Albertsons is a top-two grocer in two thirds of its major markets (as of early 2022, according to company data), and virtually all of its sales come from the United States.
Read more on ACI →About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →
